Journey Medical Corp (DERM) Operating cash flow 2020–2025
Journey Medical Corp (DERM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.4MFY2025 · since FY2020: $5.1M → -$12.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.4M | -36.3% |
| FY2024 | -$9.1M | -274.2% |
| FY2023 | $5.2M | +138.7% |
| FY2022 | -$13.5M | -520.5% |
| FY2021 | -$2.2M | -142.5% |
| FY2020 | $5.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Gross marginDERM Operating incomeDERM Operating marginDERM Free cash flowDERM Capital expendituresDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →